.pro-gallery-wix-wrapper {display: block !important;} .pro-gallery-wix-wrapper .gallery-item-container {opacity: 1 !important; display: block !important;}

Tirzepatide 15mg

Name: Tirzepatide 15mg
Brand: Kelden Peptides Canada
Price: 60 CAD
Availability: InStock
Rating: 5 (1 reviews)

Rating is 5.0 out of five stars based on 1 review

Price

$60.00

Tirzepatide 15mg is a synthetic research peptide designed to interact with both GIP and GLP-1 receptor pathways. This dual-receptor profile has made tirzepatide an important compound in laboratory research involving incretin signaling and metabolic regulation.

Research involving tirzepatide frequently examines receptor activation, glucose-related signaling systems, energy-balance pathways and the differences between single- and dual-receptor incretin models.

Kelden Peptides Canada supplies Tirzepatide 15mg as lyophilized research material in a clearly labeled format for controlled laboratory work. Researchers comparing multi-receptor compounds may also explore Retatrutide, which incorporates GLP-1, GIP and glucagon receptor activity.

Use the Kelden Peptides Canada peptide dosage calculator for research concentration calculations and review our laboratory testing information for additional quality documentation. For research use only.

Quantity

Research & Product Details

Compound: Tirzepatide Also known as: Dual GIP/GLP-1 receptor agonist Form: Lyophilized research peptide Strength: 15mg Research category: Dual incretin receptor research peptide Research overview: Tirzepatide is a synthetic research peptide designed to interact with both GIP and GLP-1 receptor pathways. Its dual-receptor profile has made it important in laboratory studies of incretin signaling, receptor activation and metabolic regulation. Research comparisons often examine how dual GIP/GLP-1 activity differs from single-receptor models and from newer triple-receptor systems such as Retatrutide. The 15mg format provides a defined quantity of the same compound for controlled experimental planning and comparative receptor research. Documentation: Published laboratory records are listed separately where available. Batch-specific testing and batch numbers can be added to this section once verified.